1104
G. Angelovski et al. / Bioorg. Med. Chem. 19 (2011) 1097–1105
4.2. Synthesis of the ligand
due was purified by column chromatography (CH2Cl2/CH3OH
93:7) to afford 764 mg (75%) of 6 as yellow viscous oil which solid-
ifies upon standing.
4.2.1. Compound 2
Cyclen (59 mg, 0.34 mmol) was dissolved in CH3CN (10 ml),
K2CO3 (458 mg, 3.31 mmol) was added and the suspension was
stirred for 15 min. Bromide 1 (465 mg, 1.65 mmol) in CH3CN
(10 ml) was added dropwise and the mixture was heated at 80 °C
for 18 h. After cooling the solid material was removed by filtration,
the solvent was evaporated and the residue purified by column
chromatography (CH2Cl2/CH3OH 92:8) to yield 290 mg (88%) of 2.
Analytical data match to those previously reported for this
molecule.30
1H NMR (CDCl3, 300 MHz): d = 7.79 (br s, 2H), 7.29–7.16 (m,
10H), 6.06 (br s, 2H), 4.99 (s, 4H), 3.33–3.08 (br, 12H), 3.02–2.75
(br, 4H), 2.55–1.95 (br, 16H), 1.32 (s, 18H). 13C{1H} NMR (CDCl3,
75 MHz): d = 172.1, 171.7, 156.8, 136.9, 128.3, 127.8, 127.7, 81.6,
66.2, 56.2, 55.5, 50.4, 40.9, 39.6, 28.0. ESI-HRMS: for
þ
C
C
44H69N8O10
:
calcd 869.5131 [M+H]+, found 869.5165; for
44H68N8NaO10þ: calcd 891.4951 [M+Na]+, found 891.4953.
4.2.5. {4,10-Bis-[(2-amino-ethylcarbamoyl)-methyl]-7-tert-
butoxycarbonylmethyl-1,4,7,10tetraaza-cyclododec-1-yl}-
acetic acid tert-butyl ester, 7
4.2.2. tert-Butoxycarbonylmethyl-{2-[2-(4,7,10-tris-{[2-(bis-tert
-butoxycarbonylmethyl-amino)-ethylcarbamoyl]-methyl}-
1,4,7,10tetraaza-cyclododec-1-yl)-acetylamino]-ethyl}-amino-
acetic acid tert-butyl ester (3)
Compound 6 (764 mg, 0.88 mmol) was dissolved in CH3OH
(50 ml) and Pd/C (200 mg) was added. After the hydrogenation at
2.5 bar (18 h), suspension was filtered through celite and solvent
was evaporated to give 7 containing carbamate residues.
1H NMR (CDCl3, 300 MHz): d = 7.98 (br s, 2H), 3.32–3.17 (br,
8H), 3.13–2.89 (br, 8H), 2.84–2.73 (br, 4H), 2.64–2.13 (br, 16H),
1.37 (s, 18H). 13C{1H} NMR (CDCl3, 75 MHz): d = 171.9, 171.6,
81.5, 56.3, 55.5, 50.5, 50.1, 41.6, 41.3, 28.0. ESI-HRMS: for
Protected amine 2 (660 mg, 0.68 mmol), was dissolved in
1.25 M methanolic HCl (20 ml) and the solution was stirred at
room temperature for 18 h. The solvent was removed on the rotary
evaporator and the residue was dissolved in water (5 ml). The pH
of the solution was adjusted to neutral using 5 M NaOH and the
water was removed on the rotary evaporator. The solid residue
and K2CO3 (1.87 g, 13.53 mmol) were suspended in CH3CN
(20 ml) and the mixture was stirred for 30 min. tert-Butyl bromo-
acetate (1.32 g, 6.77 mmol) in CH3CN (10 ml) was finally added
dropwise and the mixture was heated at 80 °C for 18 h. After cool-
ing the suspension was filtered, the solvent was evaporated and
the residue purified by column chromatography (CH2Cl2/CH3OH
96:4) to yield 533 mg (53%) of 3 as yellow viscous oil which solid-
ifies upon standing.
C
28H56N8NaO6þ: calcd 623.4215 [M+Na]+, found 623.4223.
4.2.6. (4,10-Bis-{[2-(bis-tert-butoxycarbonylmethyl-amino)-
ethylcarbamoyl]-methyl}-7-tert-butoxycarbonylmethyl-
1,4,7,10tetraaza-cyclododec-1-yl)-acetic acid tert-butyl ester, 8
Amine
7
(106 mg, 0.18 mmol), tert-butyl bromoacetate
(172 mg, 0.88 mmol) and K2CO3 (243 mg, 1.76 mmol) were mixed
in CH3CN (10 ml) and the mixture was heated at 80 °C for 18 h.
After cooling the suspension was filtered, the solvent was evapo-
rated and the residue purified by column chromatography
(CH2Cl2/CH3OH 97:3) to yield 99 mg (53%) of 8 as yellow viscous
oil.
1H NMR (CDCl3, 300 MHz): d = 7.63 (br s, 4H), 3.34 (s, 16H),
3.24–3.14 (br, 8H), 3.12–3.03 (br, 8H), 2.80–2.70 (br, 8H), 2.67–
2.48 (br, 8H), 2.43–2.27 (br, 8H), 1.38 (s, 72H). 13C{1H} NMR (CDCl3,
75 MHz): d = 171.1, 170.8, 81.2, 57.1, 55.8, 52.7, 50.4, 37.3, 28.0.
ESI-HRMS: for C72H133N12O20þ: calcd 1485.9754 [M+H]+, found
1H NMR (CDCl3, 300 MHz): d = 7.61–7.56 (br, 2H), 3.34 (s, 8H),
3.22–3.10 (br, 8H), 3.06–2.92 (br, 4H), 2.79–2.72 (br, 4H), 2.69–
2.42 (br, 8H), 2.40–2.19 (br, 8H), 1.39 (s, 36H), 1.37 (s, 18H).
13C{1H} NMR (CDCl3, 75 MHz): d = 171.7, 171.1, 171.0, 81.3, 56.5,
55.9, 55.6, 53.0, 50.6, 37.2, 28.1. ESI-HRMS: for C52H97N8O14þ: calcd
1057.7119 [M+H]+, found 1057.7139; for C52H96N8NaO14þ: calcd
1079.6938 [M+Na]+, found 1079.6926.
1485.9847; for C72H132N12NaO20 calcd 1507.9573 [M+Na]+, found
þ
1507.9577.
4.2.3. (Carboxymethyl-{2-[2-(4,7,10-tris-{[2-(bis-carboxy-
methyl-amino)-ethylcarbamoyl]-methyl}-1,4,7,10tetraaza-
cyclododec-1-yl)-acetylamino]-ethyl}-amino)-acetic acid (L1)
Compound 3 (128 mg, 0.086 mmol) was dissolved in formic
acid (5 ml) and the solution was heated at 60 °C for 18 h. After
the solution was cooled, formic acid was removed on the rotary
evaporator. The residue was dissolved in minimal amount of water,
added dropwise to cooled acetone (ꢁ20 °C) and stored in the free-
zer overnight. The acetone was decanted from the solid material
and the crude product was obtained by drying it under reduced
pressure to afford 73 mg (82%) of L1 as colourless hygroscopic
solid.
4.2.7. (4,10-Bis-{[2-(bis-carboxymethyl-amino)-ethylcar-
bamoyl]-methyl}-7-carboxymethyl-1,4,7,10tetraaza-cyclod-
odec-1-yl)-acetic acid, L2
Compound 8 (269 mg, 0.254 mmol) was dissolved in formic
acid (5 ml) and the solution was heated at 60 °C for 18 h. After
the solution was cooled, formic acid was removed on the rotary
evaporator. The residue was dissolved in minimal amount of water,
added dropwise to cooled acetone (ꢁ20 °C) and stored in the free-
zer overnight. The acetone was decanted from the solid material
and the crude product was obtained by its drying in the vacuum
to afford 145 mg (79%) of L2 as colourless hygroscopic solid.
1H NMR (D2O, 300 MHz): d = 3.90–3.79 (br, 12H), 3.63–3.45 (br,
8H), 3.44–3.28 (br, 12H), 3.20–2.94 (br, 8H). 13C{1H} NMR (D2O,
75 MHz): d = 169.7, 56.5, 55.5, 54.8, 51.1, 48.6, 34.9. ESI-HRMS:
for C28H47N8O14þ: calcd 719.3217 [MꢁH]ꢁ, found 719.3225.
1H NMR (D2O, 300 MHz): d = 3.91–3.79 (br, 24H), 3.61–3.52 (br,
8H), 3.39–3.32 (br, 8H), 3.31–3.18 (br, 16H). 13C{1H} NMR (D2O,
75 MHz): d = 169.6, 56.6, 55.6, 54.3, 50.0, 34.7. ESI-HRMS: for
C
C
40H67N12O20ꢁ: calcd 1035.4600 [MꢁH]ꢁ, found 1035.4633; for
40H66N12O202ꢁ: calcd 517.2264 [Mꢁ2H]2ꢁ, found 517.2259.
4.2.4. {4,10-Bis-[(2-benzyloxycarbonylamino-ethylcarbamoyl)-
methyl]-7-tert-butoxycarbonylmethyl-1,4,7,10tetraaza-cycl-
ododec-1-yl}-acetic acid tert-butyl ester, 6
DO2AtBu (4, 467 mg, 1.17 mmol) was dissolved in dry DMF
(3 ml) and K2CO3 (776 mg, 5.61 mmol) was added. After stirring
for 30 min, benzyl 2-(2-bromoacetamido)ethylcarbamate (5,
882 mg, 2.80 mmol) in DMF (2 ml) was added slowly and suspen-
sion was stirred for 24 h at room temperature. After that period the
suspension was filtered, the solvent was evaporated and the resi-
4.2.8. Ln3+ complexes
The Ln3+ complexes of L1 and L2 were prepared by mixing the
ligand and the LnCl3 solutions in 1:1 ratio. The solution was stirred
at 60 °C for 48 h and at room temperature for 24 h. The pH was ad-
justed to 7.0–7.5 using a solution of NaOH (1 M). After 72 h, the
mixture was stirred for 24 h at room temperature in presence of
Chelex 100. The absence of free Ln3+ (Yb3+ or Eu3+) was verified
by colorimetric assay using xylenol orange.